CKM Health Groundbreakers

Health care organizations in select areas are eligible to participate in the implementation science phase of this innovative 4-year initiative.

About the Initiative

AHA CKM HTML LOGO

Launched in 2024, the Cardiovascular-Kidney-Metabolic (CKM) Health Initiative represents a holistic, patient-centered approach to bridging gaps in fragmented care practices for people with a cluster of conditions known as CKM syndrome. CKM syndrome is made up of heart disease, kidney disease, diabetes and obesity, and leads to poor health outcomes. Information, tools and resources on CKM health care are available for professionals to begin implementing insights today.

For health care organizations in target locations, the AHA is offering participation in a new implementation science project to help build insights, test practices, and measure outcomes over the 4-year initiative.

Introducing CKM Health Groundbreaker Sites

150 sites across the U.S. will be selected, based on eligibility criteria, to participate in the implementation science project for this initiative. Aptly named “American Heart Association CKM Health Groundbreaker,” this group of health care sites will learn to forge connections across care disciplines and adopt a CKM health model of care that better aligns for patients with CKM syndrome.

Eligibility

Presently, implementation science teams are recruiting participation from health care organizations in target geographies, each selected based on health-related factors including health disparities, obesity trends, and population demographics. Health care organizations in the below areas are invited to participate in the CKM Health Initiative as CKM Groundbreaker sites.

Learn more about these selections
CKM 15 Regions Map

What does it mean to be a CKM Health Groundbreaker?

Participants in the CKM Health Groundbreaker Implementation Science project will receive specialized coaching for improved processes, resources, and communication among practitioners related to CKM Health. Results from the implementation science phase will be measured and tracked across 150 sites within the targeted geographies. As trends and insights emerge, participants will be invited to assist and advise Association teams in building out expanded resources, processes, and focused cohorts related to the 4-year initiative to guide long-term support of CKM health care. Participating sites will recieve:

Award mechanics

Quality Improvement Consultation

Stethoscope Books

Professional & patient-facing resources

Graph

Measurement & tracking support

Brainstorming

Collaboration with peer sites locally & across the US

Award Certificate

Recognition & model sharing opportunities

Dollar Envelope

Project participation stipend

Interested? Reach out.

There are many ways to engage with the CKM Health Initiative by the American Heart Association. New eligible geographies will be announced over the four-year initiative, so sign up to stay connected.

Champion Sponsor


DaVita logo

Supporting Sponsor


Novartis logo

Founding Sponsors

Novo Nordisk logo | Boehringer Ingelheim logo


The American Heart Association's Cardiovascular-Kidney-Metabolic Health Initiative is made possible by Founding Sponsors Novo Nordisk and Boehringer Ingelheim, Supporting Sponsor Novartis Pharmaceuticals Corporation, and Champion Sponsor DaVita.